KLK3 and neoplasm: performed single-cell sequencing and discovered the activated endothelial cells, KLK3-high T-cell clusters, and KLK3-positive T cells in TME for CRPC progression to elucidate the significant variability presented in PCa and offered insights for pinpointing therapeutic targets and developing robust tumor biomarkers (23).